ReachMD: The importance of extended genotyping in cervical cancer screening: The special case of HPV 31

Could an HPV test with extended genotyping that can individually identify HPV 16, 18, 31, and other genotypes change the way we manage cervical cancer screening results?

In this video, Dr. Mark Stoler, Professor of Pathology and Clinical Gynecology at the University of Virginia Health System, discusses the special case of HPV 31.

Latest resources

Discover our latest articles, webinars, press releases and updates in women's health.

Cervical Cancer Screening: The Current State of Testing
Cervical Cancer | Articles & Publications
Cervical Cancer Screening: The Current State of Testing
ReachMD: Genotype specific persistence: Looking beyond HPV 16
Cervical Cancer | Webinars & Videos
ReachMD: Genotype specific persistence: Looking beyond HPV 16
BD Onclarity™ HPV Assay with extended genotyping
Cervical Cancer | Brochures
BD Onclarity™ HPV Assay with extended genotyping